Cyproterone acetate/ethinylestradiol (CPA/EE)
JJ2015-42
Phase 2 small_molecule completed
Quick answer
Cyproterone acetate/ethinylestradiol (CPA/EE) for Polycystic Ovarian Syndrome is a Phase 2 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Polycystic Ovarian Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed